In Vermont, bills passed on Thursday protect providers who provide reproductive and gender-affirming health care services, including medication used widely in abortions, even if the U.S. Food and Drug Administration withdraws its approval of the pill, mifepristone. If the FDA approval is withdrawn, the drug companies can no longer market the drug.

The post Vermont Passes Bills aimed at protecting access to abortion pills appeared first on Balanced News Summary.